PBYI Puma Biotechnology PE ratio, current and historical analysis
As at Mar 13, 2025, the PBYI stock has a price-to-earnings ratio of 5.39. This is based on the current EPS of $0.62 and the stock price of $3.34 per share. A decrease of 50% has been recorded in the PE ratio compared to the average of 10.9 of the last four quarters.
PBYI PE ratio history
The mean historical PE ratio of Puma Biotechnology over the last three years is 16.51. The current 5.39 P/E ratio is 67% lower than the historical average. In the past three years, PBYI's PE ratio peaked in the Sep 2023 quarter at 37.57, with a price of $2.63 and an EPS of $0.07. The Dec 2024 quarter marked the lowest point at 4.92, with a price of $3.05 and an EPS of $0.62.
Puma Biotechnology PE ratio by year
Maximum annual decrease: -47.72% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 4.92 | -47.72% | $3.05 | $0.62 |
| 2023 | 9.41 | N/A | $4.33 | $0.46 |
| 2022 | N/A | N/A | $4.23 | $0 |
| 2021 | N/A | N/A | $3.04 | -$0.72 |
| 2020 | N/A | N/A | $10.26 | -$1.52 |
| 2019 | N/A | N/A | $8.75 | -$1.95 |
| 2018 | N/A | N/A | $20.35 | -$2.99 |
| 2017 | N/A | N/A | $98.85 | -$7.85 |
| 2016 | N/A | N/A | $30.7 | -$8.29 |
| 2015 | N/A | N/A | $78.4 | -$7.45 |
| 2014 | N/A | N/A | $189.27 | -$4.73 |
| 2013 | N/A | N/A | $103.53 | -$1.9 |
| 2012 | N/A | N/A | $18.75 | -$3.42 |
| 2011 | N/A | N/A | N/A | -$1.32 |
| 2010 | N/A | N/A | N/A | $0 |
Puma Biotechnology PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 4.92 | -7.34% | $3.05 | $0.62 |
| Sep 2024 | 5.31 | -69.06% | $2.55 | $0.48 |
| Jun 2024 | 17.16 | 6.85% | $3.26 | $0.19 |
| Mar 2024 | 16.06 | 70.67% | $5.3 | $0.33 |
| Dec 2023 | 9.41 | -74.95% | $4.33 | $0.46 |
| Sep 2023 | 37.57 | N/A | $2.63 | $0.07 |
| Jun 2023 | N/A | N/A | $3.53 | -$0.06 |
| Mar 2023 | 30.9 | N/A | $3.09 | $0.1 |
| Dec 2022 | N/A | N/A | $4.23 | $0 |
| Sep 2022 | 10.77 | N/A | $2.37 | $0.22 |
| Jun 2022 | N/A | N/A | $2.85 | -$0.86 |
| Mar 2022 | N/A | N/A | $2.88 | -$1.2 |
| Dec 2021 | N/A | N/A | $3.04 | -$0.72 |
| Sep 2021 | N/A | N/A | $7.01 | -$1.19 |
| Jun 2021 | N/A | N/A | $9.18 | -$0.89 |
PBYI average PE ratio chart
The current PE ratio of PBYI is lower than the 3, 5 and 10-year averages.
PBYI PE vs peers
In comparison to its peer stock PFE, PBYI's PE ratio is lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PBYI Puma Biotechnology Inc | 5.39 | $165.7M |
| PFE Pfizer Inc | 18.03 | $145.08B |
| ARRY Array Technologies Inc | N/A | $921.2M |
Frequently asked questions
What is Puma Biotechnology's PE ratio?
The price to earnings ratio for PBYI stock is 5.39 as of Mar 13, 2025.
What is the 3-year average PE ratio for Puma Biotechnology (PBYI)?
Over the last 3 years, the average price to earnings ratio for PBYI stock is 16.51.
What is the 5-year average PE ratio for Puma Biotechnology (PBYI)?
Over the last 5 years, the average price to earnings ratio for PBYI stock is 16.51.
What is the highest PE ratio for PBYI?
The highest quarterly PE ratio in the last three years has been 37.57 and it was in the Sep 2023 quarter.
How does the current PE ratio for PBYI compare to its historical average?
PBYI's current price to earnings ratio is 67% below its 3-year historical average.
Why is Puma Biotechnology's PE ratio so low?
PBYI's PE ratio of 5.39 is considered low because the company's stock price is trading at a lower multiple of earnings.
How is PBYI's PE ratio calculated (Puma Biotechnology PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Mar 13, 2025), Puma Biotechnology's stock price is $3.34. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.62. Therefore, Puma Biotechnology's PE ratio for today is 5.39. PE RATIO(5.39) = STOCK PRICE($3.34) / TTM EPS($0.62)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.